AMWL American Well Corporation - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AMWL Stock | Fundamental Analysis & Investment Insights
NYSE
Healthcare
Health Information Services
Current Price
Live
$4.87
Analyst Target
$7.0
+43.7%
Upside
52W High
$12.95
52W Low
$3.71
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
88%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a critically weak financial profile with a Piotroski F-Score of just 1/9, indicating severe operational and financial distress. Despite a low Price/Book and Price/Sales ratio suggesting potential value, persistent unprofitability, negative earnings momentum, and deteriorating revenue growth paint a bleak picture. Insider selling activity and a lack of analyst consensus further undermine confidence, while the company's long-term price performance has been catastrophic, down 99.3% over five years. Although the balance sheet shows low leverage and strong liquidity, these are overshadowed by systemic profitability and growth failures.
Key Strengths
Strong liquidity position with Current Ratio of 3.13 and Quick Ratio of 2.96 provides short-term financial flexibility.
Low Debt/Equity ratio of 0.02 indicates minimal reliance on debt financing and low financial risk from leverage.
Gross Margin of 52.59% reflects pricing power or efficient cost control at the production level.
Trading at deep value multiples: Price/Book of 0.31 and Price/Sales of 0.30 suggest potential undervaluation relative to assets and revenue.
Recent quarters show improved earnings surprise trends, beating estimates in 2 of the last 4 periods with an average beat of 18.31%.
Key Risks
Critically low Piotroski F-Score of 1/9 signals widespread financial weakness across profitability, leverage, and operating efficiency.
Persistent unprofitability with Profit Margin of -42.80% and ROE of -37.05% eroding shareholder value.
Revenue declining YoY by 7.80%, indicating shrinking top-line and potential loss of market relevance.
Insiders have been consistently selling shares, with $0.40M in net sales over the past 6 months, signaling lack of confidence.
Catastrophic long-term price performance: 5-year return of -99.3% raises structural concerns about business viability.
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare AMWL against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning AMWL from our newsroom.
Newest → oldest
No matching news yet.